8:30 – 8:40 a.m.
Michael Sheldon, PhD, Director, Stem Cell Laboratory, RUCDR Infinite Biologics
8:40 – 10:00 a.m.
Part I: Large Scale iPSC Initiatives Around the World
- Michael P. Yaffe, California Institute for Regenerative Medicine- “California's hiPSC Derivation and Banking Initiative”
- Ludovic Vallier, Cambridge Biomedical Research Centre , “UK Human Induced Pluripotent Stem Cell Initiative (HIPSCI): Genotype to Phenotype"
- Chihiro Akazawa, Tokyo Medical and Dental University (TMDU), “iPS Cell Banking in Japan”
- Scott Noggle, New York Stem Cell Foundation (NYSCF) Laboratory , “Large-scale automated iPSC production and differentiation"
10:30 – 12:15 p.m.
Part II: Establishing a Global Network of Resources
- David Panchision, National Institute of Mental Health, "Prospects for Patient-Derived Reprogrammed Cells as Tools to Study & Treat Mental Illness"
- Christian Freund, Leiden University Medical Centre (LUMC), "What Could a hiPSC Core Facility Offer as Service? A Dutch Example"
- Michael Sheldon, Stem Cell Laboratory, RUCDR Infinite Biologics, "Spreading the Wealth: The Role of Biorepositories in Standardization and Distribution of Resources"
- Tenneille Ludwig, WiCell Stem Cell Bank, "Optimizing Cell Quality While Preserving Privacy: Striking a Balance Between Data Sharing and Donor Protection"
- Russ Hager, BioStorage Technologies, Inc., "Best Practices and Successful Strategies for Managing Global Logistics Networks and International Sample Collections"
- Ludovic Vallier, Cambridge Biomedical Research Centre, Closing Remarks and Future Directions